Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

January 8, 2021

Study Completion Date

January 8, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

NaxRedy ™

5 mg (5 mg/0.5 mL) IM autoinjector injection into lateral thigh

DRUG

Naloxone Hydrochloride Injection, USP

2 mg IM (2mg/2 mL) injection into gluteal muscle

DRUG

Naloxone Hydrochloride Injection, USP

2 mg bolus IV (2mg/2 mL)

Trial Locations (1)

New Haven Clinical Research Unit, New Haven